z-logo
Premium
Differences in the Reactivity of CD4 + T‐Cell Lines Generated against Free Versus Nucleosome‐Bound SV40 Large T Antigen
Author(s) -
Bredholt G.,
Rekvig O.P.,
Andreassen K.,
Moens U.,
Marion T.N.
Publication year - 2001
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1046/j.1365-3083.2001.00873.x
Subject(s) - antigen , anti nuclear antibody , biology , immune system , microbiology and biotechnology , antibody , immunology , virology , autoantibody
Previous results have revealed a strong correlation between polyomavirus BK reactivation and disease activity and antinuclear auto‐antibody production in the human autoimmune disease systemic lupus erythematosus. BK virus establishes a latent infection in most humans, and reactivation requires the production of the DNA‐binding large T antigen. Experimentally induced expression of the polyomavirus SV40 large T antigen in mice induces both an immune response to large T antigen and autoimmune response to nuclear antigens and antinuclear antibody production. Previous results have indicated that human T‐antigen‐specific CD4 + T‐cell lines are stimulated equally by free, soluble and nucleosome‐bound T antigen. This study was designed to determine how antigen processing of nucleosomes containing bound SV40 large T antigen may affect the specificity and response characteristics of experimentally induced T‐antigen‐specific CD4 + T cells. The results indicated that CD4 + T‐cell lines generated from mice immunized with soluble, free T antigen responded very poorly in response to stimulation with T antigen bound to nucleosomes. CD4 + T‐cell lines generated from mice immunized with nucleosomes that had bound T antigen in situ responded to both free and nucleosome‐bound T antigen. The T‐antigen‐specific, CD4 + memory T cells induced by latent polyomavirus infections in humans may be uniquely suited to initiate autoimmunity to nuclear antigens upon virus reactivation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here